Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure

被引：0

作者：

Ragnar Watz

Ann-Britt Ekstrand

Victoria Engelbrektson

Björn Beermann

机构：

[1] Kristinehamn’s Hospital,Department of Medicine

[2] Medical Products Agency,undefined

来源：

European Journal of Clinical Pharmacology | 2005年 / 61卷

关键词：

Heart Failure; Chronic Heart Failure; Heart Failure Patient; Carvedilol; Angiotensin Converting Enzyme Inhibitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：209 / 214

页数：5

共 50 条

[21] Polypharmacy in chronic heart failure: practical issues regarding the use of angiotensin-converting enzyme inhibitors, beta-blockers and other drugs
de Boer, RA
van Veldhuisen, DJ
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0D) : D111 - D116
[22] COMPARISON OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, CALCIUM ANTAGONISTS AND BETA-BLOCKERS ON ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE DIABETIC PATIENTS
Falkovskaya, A. Y.
Mordovin, V. F.
Belokopytova, N. V.
JOURNAL OF HYPERTENSION, 2009, 27 : S238 - S238
[23] Angiotensin converting enzyme inhibitors in management of patients with chronic heart failure
Tereshchenko, S. N.
Dzhaiani, N. A.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (03) : 83 - 88
[24] DOSE COMPARISON OF ANGIOTENSIN II-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN CONGESTIVE HEART FAILURE
Egiziano, G.
Behlouli, H.
Pilote, L.
Daskalopoulou, S. S.
CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S172 - S173
[25] Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability
Correale, Michele
Zicchino, Stefano
Monaco, Ilenia
Di Biase, Matteo
Brunetti, Natale Daniele
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 : E24 - E27
[26] Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
Ibrahim O.A.
Dunlap M.E.
Current Heart Failure Reports, 2005, 2 (2) : 89 - 93
[27] Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease
Vlachogiannakos, J
Tang, AKW
Patch, D
Burroughs, AK
GUT, 2001, 49 (02) : 303 - 308
[28] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
Benenson, Irina
JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
[29] Angiotensin-converting enzyme inhibitors and β-blockers in African American heart failure patients
McCullough, PA
Philbin, EF
Spertus, JA
Sandberg, KR
Kaatz, S
AMERICAN HEART JOURNAL, 2002, 144 (05) : 920 - 921
[30] Cost of Heart Failure in Patients Receiving β-Blockers and Angiotensin-Converting Enzyme Inhibitors
William S. Weintraub
Hugh Kawabata
Michele Tran
Gilbert J. L’italien
Roland S. Chen
Clinical Drug Investigation, 2004, 24 : 255 - 264

← 1 2 3 4 5 →